EventsThe 1st International Online Conference on Healthcare
Published
This submission belongs to the session S2. Patient-Centered Care—Optimizing Care Pathways through Engagement and Outcome Measurement of the event The 1st International Online Conference on Healthcare
Published date
20 Mar, 2026
Academic Editor
author-avatarLorraine S. Evangelista
Citation
Abdul Ajeed Mohathasim Billah, R Kavitha, M Muhilan, S Layavarshini, Kirthana Bubalan, Parameswaran V. Yamini, Patterns of Adverse Drug Reactions Observed in a Tertiary Care Hospital's Specialised Units, in Proceedings of The 1st International Online Conference on Healthcare, 25 March–26 March 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Patterns of Adverse Drug Reactions Observed in a Tertiary Care Hospital's Specialised Units

M Muhilan 1
S Layavarshini 1
Kirthana Bubalan 1
Parameswaran V. Yamini 1
1. Department of Pharmacy Practice, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai – 600116, India, India
2. Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai – 600116, India, India
Abstract

Introduction:
Adverse drug reactions (ADRs) remain a major challenge in specialised hospital units, where patients often present with complex illnesses and receive multiple medicines. Early identification and structured reporting are essential for preventing avoidable harm and improving therapeutic outcomes. This study examined the patterns, severity, causality, preventability, and outcomes of ADRs reported from specialised care units in a tertiary teaching hospital.

Methods:
A prospective cohort study was undertaken over three months in the intensive care settings of two specialised blocks within a tertiary hospital. Inpatients of all age groups were monitored for suspected ADRs following medicine administration. Data were collected using standardised ADR reporting forms adopted from the national pharmacovigilance system. Each ADR was assessed for causality using the WHO-UMC scale, severity using the Hartwig–Siegel scale, seriousness based on PvPI criteria, and preventability using the modified Schumock–Thornton method.

Results:
A total of 97 ADRs were identified. Adults accounted for most cases, with a balanced distribution between males and females. Probable ADRs formed the largest proportion (86.6%). Most reactions were mild and definitely preventable. Antibiotics were the most common drug class implicated, and skin-related hypersensitivity reactions were predominant. Almost all patients recovered fully following appropriate clinical management, including drug withdrawal or supportive treatment.

Conclusions:
The findings highlight the need for strengthened ADR monitoring in specialised units, with a particular focus on antimicrobial use and hypersensitivity reactions. Enhanced clinical pharmacist involvement and structured reporting systems may improve medicine safety and patient outcomes.

Keywords: Adverse Drug Reactions, Intensive Care, Pharmacovigilance, Causality Assessment, Patient Safety

Keywords
Adverse Drug Reactions
Intensive Care
Pharmacovigilance
Causality Assessment
Patient Safety
Oral Presentation
Navigating AI in OT Practice: Current Usage Patterns and Professional Concerns
Optimizing Clinical Trial Screening with LLMs: A New Era in Healthcare Technology